HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding

Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the profound benefits such medicines can offer.

By STAT News · May 13, 2026 · via STAT News
STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

Tags
pipelineformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Pipeline
All Pipeline →
Alkermes’ Lumryz clears phase 3 in idiopathic hypersomnia, intensifying Jazz rivalry
PipelineBriefing
Three months post-Avadel acquisition, Alkermes’ Lumryz met all endpoints in the phase 3 Revitalyz study for id…
May 13, 2026
BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial
PipelinePharmaceutical Technology ↗
An indirect comparison highlights the potential of BridgeBio's Attruby to best Pfizer’s tafamidis in frontline…
May 12, 2026
Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data
PipelineFierceBiotech ↗
Adding Inhibrx Biosciences’ OX40 agonist to Keytruda doubled the response rate in a midphase clinical trial, e…
May 12, 2026